Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-01

Clinical Trial Update: Combined Effect of TCC-I and BATD on Depressive Symptoms and Insomnia [NA]

View source ↗

Summary

This clinical trial is evaluating the combined effect of TCC-I and BATD on depressive symptoms and insomnia; the study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Liege | Conditions: Depression - Major Depressive Disorder, Insomnia | NA | Status: ENROLLING_BY_INVITATION